LacriJet®| Preloaded & Self-Retaining Monocanalicular Nasolacrimal Intubation | Exclusive | FCI Lacrimal
LacriJet® is FCI latest and exclusive preloaded & self-retaining monocanalicular nasolacrimal intubation indicated for epiphora, congenital nasolacrimal duct obstruction and canalicular laceration. LacriJet® consists of a single use injector handpiece into which a silicone tube is preloaded inside a metallic probe. Its special design enables to reduce operating time, either in the intubation phase as well as for the removal of the device.
Learn more at: 🌐 https://www.fciworldwide.com/products...
Follow us on LinkedIn: 🖥️ 
/ fci-ophthalmics
Veröffentlicht am 20.01.2025
